Predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance
Site Search
Site Search
Displaying results 271 - 280 of 519
Framework for clinical trial participants data reutilization for a fully transparent and ethical ecosystem
9/06/2021 14:00 - 15:30
IMI has had ‘big data’ projects since its creation. What’s more, the projects are putting ‘big data’ principles into practice to advance research in the fields of cardiovascular disease...
8/06/2021 14:00 - 15:30
IMI has a strong diabetes project portfolio, covering T1, T2 and diabetes complications, with several projects addressing different aspects of those diseases. Some are studying the underlying causes...
15/06/2021 14:00 - 15:00
IMI has over 20 projects in this area accounting for around 10 % of IMI’s budget. Most focus on Alzheimer’s disease, the most prevalent cause of dementia, but we also have projects on other dementia...
09/12/2021
DRIVE found fewer options for older people, and that younger people’s other risk factors play a part in the choice. This data is helping calculate the effectiveness of vaccination...
7/10/2021 14:00 - 15:30
For many years, patient involvement in research was restricted to participating in clinical studies and trials as research subjects. Today, it is widely recognised that patients can and should be much...
Medical innovation has often been slow to trickle down to children and adolescents. IHI and IMI's paediatric research portfolios are changing that.
Used wisely, big data has the potential to revolutionise research.
Patients can and should be much more involved in all aspects of research.